Research and Development Committee

Priority Issues

Follow-up and proposal of science, technology and innovation policies related to health, medicine and life science
Pharmaceutical Manufacturers Association of Japan Promotion of activities to realize the industry vision and policy recommendations
Development and strengthening of science and technology infrastructure related to drug discovery research
Promotion of translational research and infrastructure development
Promote industry-academia-government collaboration for the creation of healthcare innovation

Collaborate with the Industrial Policy Committee, etc., to make recommendations for policies in the health and medical care and life science fields.
Collaboration with relevant government ministries and agencies and related stakeholders for pharmaceutical R&D and issuing specific opinions
Collaboration with the Pharmaceuticals and Healthcare-related Division of the Japan Agency for Medical Research and Development (AMED)

Promotion of R&D measures based on policy recommendations of the Pharmaceutical Manufacturers Association of Japan (PMAJ) and collaboration with other committees
Study and promotion of measures to improve the environment for innovative drug discovery

Study and promotion of measures to apply new fundamental technologies to drug discovery research
Recommendations for improvement of drug discovery research capabilities and environment

Study and propose measures to revitalize and promote translational research and the development of its infrastructure
Examination of measures to promote personalized medicine based on the development of infrastructures for the utilization of medical information

Study and proposal on how to strengthen and activate industry-academia-government collaboration with academia at the core
Examination, promotion, and proposal of a new framework for the creation of a wide range of healthcare solutions